Clinical Trial Update: Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study update evaluating disulfiram for glioblastoma following standard therapy with radiation and temozolomide; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Disulfiram (Disulfiram)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma | EARLY_Phase 1 | Status: COMPLETED